Trial intelligence / Profile preview

Alimta in Advanced Thymoma and Thymic Carcinoma

NCT00198133Phase 2Completed

Start
Jan 2005
Primary completion
Dec 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pemetrexed in thymoma, thymic carcinoma (TC). Started Jan 2005; status: completed.

02

Drugs

pemetrexed
03

Conditions

thymomathymic carcinoma (TC)

Beyond the preview

Go deeper on NCT00198133.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00198133.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call